SCHEMBL6422844

SCHEMBL6422844

Cc1c(C(C(=O)O)C(C)C)c2c(F)c(O)ccc2n1C(=O)c1cccc(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
PIK3CD O00329 1/20 0.35
PLA2G7 Q13093 1/20 0.35
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35
NOTUM Q6P988 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424956 0.90 AKR1C3 (0.38) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL5560372 0.90 AKR1C3 (0.38) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL6423624 0.90 AKR1C3 (0.38) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL6425560 0.90 AKR1C3 (0.38) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL5561345 0.90 AKR1C3 (0.38) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL6428539 0.90 POLB (0.36) AKR1C3AKR1C2KMT2AMEN1NOTUM
SCHEMBL5557670 0.90 AKR1C3 (0.40) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL5547108 0.90 AKR1C3 (0.40) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL5554693 0.90 AKR1C3 (0.40) AKR1C3AKR1C2PIK3CDPLA2G7MAPT
SCHEMBL5554388 0.87 AKR1C3 (0.36) AKR1C3AKR1C2PIK3CDPLA2G7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 AKR1C3 577/4885AKR1C2 563/4885PIK3CD 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.